237 related articles for article (PubMed ID: 23454185)
1. Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
des Rieux A; Pourcelle V; Cani PD; Marchand-Brynaert J; Préat V
Adv Drug Deliv Rev; 2013 Jun; 65(6):833-44. PubMed ID: 23454185
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yun Y; Cho YW; Park K
Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
[TBL] [Abstract][Full Text] [Related]
3. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination.
Fievez V; Plapied L; des Rieux A; Pourcelle V; Freichels H; Wascotte V; Vanderhaeghen ML; Jerôme C; Vanderplasschen A; Marchand-Brynaert J; Schneider YJ; Préat V
Eur J Pharm Biopharm; 2009 Sep; 73(1):16-24. PubMed ID: 19409989
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of proteins by biodegradable nanoparticles.
Bakhru SH; Furtado S; Morello AP; Mathiowitz E
Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
Chen MC; Mi FL; Liao ZX; Hsiao CW; Sonaje K; Chung MF; Hsu LW; Sung HW
Adv Drug Deliv Rev; 2013 Jun; 65(6):865-79. PubMed ID: 23159541
[TBL] [Abstract][Full Text] [Related]
6. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
7. Oral drug delivery systems using chemical conjugates or physical complexes.
Al-Hilal TA; Alam F; Byun Y
Adv Drug Deliv Rev; 2013 Jun; 65(6):845-64. PubMed ID: 23220326
[TBL] [Abstract][Full Text] [Related]
8. Development of PLGA-mannosamine nanoparticles as oral protein carriers.
Alonso-Sande M; des Rieux A; Fievez V; Sarmento B; Delgado A; Evora C; Remuñán-López C; Préat V; Alonso MJ
Biomacromolecules; 2013 Nov; 14(11):4046-52. PubMed ID: 24131254
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.
Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y
Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863
[TBL] [Abstract][Full Text] [Related]
11. Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.
des Rieux A; Fievez V; Momtaz M; Detrembleur C; Alonso-Sande M; Van Gelder J; Cauvin A; Schneider YJ; Préat V
J Control Release; 2007 Apr; 118(3):294-302. PubMed ID: 17292503
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
des Rieux A; Fievez V; Garinot M; Schneider YJ; Préat V
J Control Release; 2006 Nov; 116(1):1-27. PubMed ID: 17050027
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.
Roger E; Lagarce F; Garcion E; Benoit JP
Nanomedicine (Lond); 2010 Feb; 5(2):287-306. PubMed ID: 20148639
[TBL] [Abstract][Full Text] [Related]
15. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
Kriegel C; Attarwala H; Amiji M
Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
17. In vitro identification of targeting ligands of human M cells by phage display.
Fievez V; Plapied L; Plaideau C; Legendre D; des Rieux A; Pourcelle V; Freichels H; Jérôme C; Marchand J; Préat V; Schneider YJ
Int J Pharm; 2010 Jul; 394(1-2):35-42. PubMed ID: 20417702
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
[TBL] [Abstract][Full Text] [Related]
19. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
20. Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach.
Soudry-Kochavi L; Naraykin N; Nassar T; Benita S
J Control Release; 2015 Nov; 217():202-10. PubMed ID: 26381898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
